Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 221, No. 1, 2007   

Free Abstract     Article (Fulltext)     Article (PDF 215 KB)     

Original Paper

Antiphospholipid Antibodies in Ocular Arterial and Venous Occlusive Disease
Anja M. Palmowski-Wolfea, Elke Denningerb, Jürgen Geiselc, Gerhard Pindurd, Klaus W. Ruprechtb

aEye Hospital, University of Basel, Basel, Switzerland;
bEye Hospital,
cInstitute of Laboratory Medicine, and
dInstitute of Haemostaseology and Transfusion Medicine, University of Saarland, Homburg, Germany

Address of Corresponding Author

Ophthalmologica 2007;221:41-46 (DOI: 10.1159/000096521)


 goto top of page Key Words

  • Antiphospholipid antibodies
  • Lupus anticoagulants
  • Anticardiolipin antibodies
  • Retinal artery occlusion
  • Retinal vein occlusion
  • Anterior ischemic optic neuropathy
  • Posterior ischemic optic neuropathy

 goto top of page Abstract

Purpose: It was the aim of this study to evaluate antiphospholipid antibodies (APA), i.e. lupus anticoagulants (LA) and anticardiolipin (ACA) IgG and IgM, in ophthalmic occlusive disease. Methods: Over a 3.5-year period, APA were evaluated in 368 patients. Results: Eighty-six patients (23.4%), compared to 5% in the general population, tested positive for APA. APA did not differ significantly between patients with venous (20.6%) or arterial (25.5%) occlusive disease. This included 93 patients with central retinal vein occlusion (18% APA positive), 67 with retinal branch vein occlusion (24% APA positive), 41 with central retinal artery occlusion (22% APA positive), 53 with retinal branch artery occlusion (32% APA positive), 71 with anterior ischemic optic neuropathy (23% APA positive), 12 with posterior ischemic optic neuropathy (33% APA positive) and 31 patients with amaurosis fugax (23% APA positive). Excluding patients with accepted main risk factors, APA were positive in 15.3% of 85 patients. Conclusion: The high APA prevalence confirms its relevance in ocular occlusive disorders.

Copyright © 2007 S. Karger AG, Basel


 goto top of page Author Contacts

Anja M. Palmowski-Wolfe, MD
University of Basel
Eye Hospital, Mittlere Strasse 91
CH-4051 Basel (Switzerland)
Tel. +41 61 265 8722, Fax +41 61 265 8744, E-Mail palmowskiA@uhbs.ch


 goto top of page Article Information

Presented in part at the annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, April 2004.

Received: February 23, 2006
Accepted after revision: April 27, 2006
Number of Print Pages : 6
Number of Figures : 4, Number of Tables : 0, Number of References : 23

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 17183200)
Download Citation




For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2009 S. Karger AG, Basel